BCP
Berkeley Capital Partners’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-5,767
| Closed | -$271K | – | 120 |
|
|
2019
Q4 | $271K | Sell |
5,767
-1,600
| -22% | -$75.2K | 0.14% | 118 |
|
|
2019
Q3 | $314K | Sell |
7,367
-1,262
| -15% | -$53.8K | 0.17% | 107 |
|
|
2019
Q2 | $345K | Sell |
8,629
-2,008
| -19% | -$80.3K | 0.16% | 103 |
|
|
2019
Q1 | $445K | Buy |
10,637
+754
| +8% | +$31.5K | 0.22% | 88 |
|
|
2018
Q4 | $378K | Buy |
+9,883
| New | +$378K | 0.21% | 87 |
|
|
2018
Q3 | – | Sell |
-8,460
| Closed | -$341K | – | 117 |
|
|
2018
Q2 | $341K | Sell |
8,460
-1,912
| -18% | -$77.1K | 0.2% | 92 |
|
|
2018
Q1 | $405K | Sell |
10,372
-2,058
| -17% | -$80.4K | 0.23% | 88 |
|
|
2017
Q4 | $441K | Sell |
12,430
-421
| -3% | -$14.9K | 0.29% | 83 |
|
|
2017
Q3 | $522K | Buy |
12,851
+5,456
| +74% | +$222K | 0.35% | 77 |
|
|
2017
Q2 | $319K | Sell |
7,395
-921
| -11% | -$39.7K | 0.22% | 92 |
|
|
2017
Q1 | $351K | Sell |
8,316
-5,100
| -38% | -$215K | 0.24% | 90 |
|
|
2016
Q4 | $517K | Buy |
13,416
+5,772
| +76% | +$222K | 0.37% | 67 |
|
|
2016
Q3 | $330K | Buy |
7,644
+103
| +1% | +$4.45K | 0.24% | 83 |
|
|
2016
Q2 | $327K | Sell |
7,541
-3,679
| -33% | -$160K | 0.23% | 83 |
|
|
2016
Q1 | $455K | Buy |
11,220
+4,387
| +64% | +$178K | 0.33% | 63 |
|
|
2015
Q4 | $276K | Buy |
+6,833
| New | +$276K | 0.22% | 84 |
|